Strata Critical Medical, Inc. provides time-critical logistics and medical services to the healthcare industry in the United States. It operates in two segments, Logistics and Clinical. The company offers logistics services, such as air and ground transportation for human organs, transplant teams, and related medical materials and organ placement services; transplant clinical services, including organ recovery procedures, normothermic regional perfusion, and preservation services. It also provides other clinical services comprising cardiac perfusion services, blood management and autotransfusion services, extracorporeal membrane oxygenation services, perfusion staffing, and equipment rentals. The company was formerly known as Blade Air Mobility, Inc. and changed its name to Strata Critical Medical, Inc. in August 2025. The company was founded in 2014 and is headquartered in New York, New York.…
Strata Critical Medical Inc (SRTA) (Q3 2026) Earnings Call Highlights: Revenue Surges 50% as ...
Strata Critical Medical (NASDAQ: SRTA) is listed on Nasdaq, where its shares trade in USD. It belongs to the Medical Care Facilities industry, part of the Healthcare sector, and reports about 327 employees.
The shares were at 4.560 USD on 20 November 2026, down 1.9% over 52 weeks. Its 52-week range is 3.950 USD to 6.460 USD: the price is 29.4% below the high and 15.4% above the low.
Its market capitalisation is 407.30M USD.
Strata Critical Medical reports return on equity of 14.8%, an operating margin of -4.7% and revenue up 50.3% year over year.
It holds more cash than debt, a net cash position of 38.02M USD. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 4 analysts cover the stock; their mean price target of 9.625 USD is 111.1% above the current price. The next earnings report is expected on 2 March 2027.